Peroxisome proliferator-activated receptors: A family of lipid-activated transcription factors

American Journal of Clinical Nutrition

Volumn 70, Issue 4, 1999, Pages 566-571

  Clarke, Steven D ^a   Thuillier, Philippe ^a   Baillie, Rebecca A ^a   Sha, Xiaoming ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Differentiation; Fat cells; Fatty acid synthase; Fatty acids; Peroxisome proliferator activated receptor; Retinoid receptor X ; Review; Transcription factor

Indexed keywords

FATTY ACID SYNTHASE; PEROXISOME PROLIFERATOR; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANIMAL CELL; CONFERENCE PAPER; DNA BINDING; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; LIPID METABOLISM; NONHUMAN; PROTEIN FAMILY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SURVIVAL; TRANSCRIPTION REGULATION;

EID: 0032867442     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.4.566     Document Type: Conference Paper

References (66)

1. Storlien LJ, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high fat feeding in rats. Science 1987;237:885-8.
2. Gasperikova D, Klimes I, Kolter T, et al. Glucose transport and insulin signaling in rat muscle and adipose tissue: effect of lipid availability. Ann N Y Acad Sci 1997;827:144-57.
3. Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin M. Dietary polyunsaturated fatty acid regulation of gene transcription. Prog Lipid Res 1996;35:227-41.
4. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996;37:907-25.
5. Takada R, Saitoh M, Mori T. Dietary gamma-linolenic acid enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid beta-oxidation in rats. J Nutr 1994;124:469-74.
6. Power GW, Newsholme EA. Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle. J Nutr 1997;127:2142-50.
7. Miller CC, Ziboh VA. Induction of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE). J Invest Dermatol 1990;94:353-8.
8. Kidwell WR. Fatty acid growth requirements of normal and neoplastic mammary epithelium. Prog Clin Biol Res 1986;222:699-707.
9. Lambe KG, Tugwood JD. A human peroxisome-proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 1996;239:1-7.
10. Clarke SD, Jump DB. Dietary polyunsaturated fatty acid regulation of gene transcription. Annu Rev Nutr 1994;14:83-98.
11. Clarke SD, Jump DB. Fatty acid regulation of gene expression; a unique role for polyunsaturated fats. In: Berdanier CD, Hargrove JL, eds. Nutrition and gene expression. Boca Raton, FL: CRC Reviews, 1992:227-45.
12. Clarke SD, Turini M, Jump DB, Abraham S, Reedy M. Polyunsaturated fatty acid inhibition of fatty acid synthase transcription is independent of PPAR activation. Z Ernahrungswiss 1998;37(s):14-20.
13. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-50.
14. Wahli W, Martinez E. Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J 1991;5:2243-9.
15. Tzameli I, Zannis VI. Binding specificity and modulation of the apo A-I promoter activity by homo- and heterodimers of nuclear receptors. J Biol Chem 1996;271:8402-15.
16. Stroup D, Crestani M, Chiang JYL. Orphan receptors chicken ovalbumin upstream promoter transcription factor II (COUP-TF II) and retinoid X receptor (RXR) activate and bind the rat cholesterol 7α-hydroxylase gene (CYP7A). J Biol Chem 1997;272:9833-9.
17. Lala DS, Syka PM, Lazarchik SB, Mangelsdorf DJ, Parker KL, Heyman RA. Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci U S A 1997;94:4895-900.
18. Mukherjee R, Jow L, Croston GE, Paterniti JR. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 1997;272:8071-6.
19. Enmark E, Gustafsson JA. Orphan nuclear receptors - the first eight years. Mol Endocrinol 1996;10:1293-307.
20. Ren B, Thelen A, Jump DB. Peroxisome proliferator-activated receptor a inhibits hepatic S14 gene transcription. J Biol Chem 1996;271:17167-73.
21. Brun RP, Kim JB, Hu E, Altiok S, Spiegelman BM. Adipocyte differentiation: a transcriptional regulatory cascade. Cur Opin Cell Biol 1996;8:826-32.
22. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. J Biol Chem 1995;270:2367-71.
23. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9:1033-45.
24. Forman BM, Goode E, Chen J, et al. Identification of a nuclear receptor that is activated by famesol metabolites. Cell 1995;81:687-93.
25. Thuillier P, Baillie R, Sha X, Clarke SD. Cytosolic and nuclear distribution of PPARγ2 in differentiating 3T3-L1 preadipocytes. J Lipid Res 1998;39:2329-38.
26. Mukherjee R, Davies PJA, Crombie DL, et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 1997;386:407-10.
27. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841-50.
28. Miyamoto T, Kaneko A, Kakizawa T, et al. Inhibition of peroxisome proliferator signaling pathways by thyroid hormone receptor. J Biol Chem 1997;272:7752-8.
29. Krey G, Mahfoudi A, Wahli W. Functional interactions of peroxisome proliferator-activated receptor, retinoid-X receptor, and Sp1 in the transcriptional regulation of the acyl-coenzyme A oxidase promoter. Mol Endocrinol 1995;9:219-31.
30. Chu R, Madison LD, Lin Y, et al. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding β-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc Natl Acad Sci U S A 1995;92:11593-7.
31. Kliewer SA, Forman BM, Blumber B, et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 1994;91:7355-9.
32. Gottlicher M, Widmark E, Li Q, Gustafsson JA. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1992;89:4653-7.
33. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997;11:779-91.
34. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc Natl Acad Sci U S A 1997;94:4318-23.
35. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 1992;6:1634-41.
36. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci U S A 1997;94:4312-7.
37. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 1998;273:8560-3.
38. Rodriguez JC, Gil-Gomez B, Hegradt FG, Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 1994;269:18767-72.
39. Varanasi U, Chu R, Huang Q, Castellon R, Yeldani AV, Reddy JK. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J Biol Chem 1996;271:2147-55.
40. Clarke SD, Turini M, Jump DB. Polyunsaturated fatty acids regulate lipogenic and peroxisomal gene expression by independent mechanisms. Prostaglandins Leukot Essent Fatty Acids 1997;57:65-9.
41. Aubert J, Champigny O, Saint-Marc P, et al. Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells. Biochem Biophys Res Commun 1997;238:606-11.
42. Baillie R, Takada R, Nakamura M, Clarke SD. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids (in press).
43. Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 1998;273:29577-85.
44. 4 pathway to inflammation control. Nature 1996;384:39-43.
45. Yu K, Bayona W, Kallen CB, et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995;270:23975-83.
46. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-deoxy-d-12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995;83:803-12.
47. DuBois RN, Gupta R, Brockman J, Reddy BS, Krakow SL, Lazar MA. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis 1998;19:49-53.
48. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995;83:813-9.
49. Berger J, Bailey P, Biswas C, et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor[hyphen]γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 1996;137:4189-95.
50. Lehmann J, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1995;270:12953-6.
51. Harris PKW, Kletzien RF. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Mol Pharmacol 1994;45:439-45.
52. Kletzien RF, Foellmi LA, Harris PKW, Wyse BM, Clarke SD. Adipocyte fatty acid binding protein (aFABP): regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent. Mol Pharmacol 1992;42:558-62.
53. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331:1188-93.
54. γ mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol. Am J Physiol 1994;267:E95-101.
55. Hofmann C, Lorenz K, Colca J. Glucose transport deficiency in diabetic animals is corrected by treatment with oral antihyperglycemic agent pioglitazone. Endocrinology 1991;129:1915-25.
56. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA, Evans RM. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998;93:241-52.
57. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-9.
58. Shalev A, Siegrist-Kaiser CA, Yen PM, et al. The peroxisome proliferator-activated receptor α is a phosphoprotein: regulation by insulin. Endocrinology 1996;137:4499-502.
59. Werman A, Hoolenberg A, Solanes G, Bjorbaek C, Vidal-Puig AJ, Flier JS. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1997;272:20230-5,
60. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 1996;274:2100-3.
61. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen activated protein kinase site. J Biol Chem 1997;271:5128-32.
62. Clarke SD, Baillie R, Jump DB, Nakamura M. Fatty acid regulation of gene expression: its role in fuel partitioning and insulin resistance. Ann N Y Acad Sci 1997;827:178-86.
63. Ren B, Thelen AP, Peters JM, Gonzalez FJ, Jump DB. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor α. J Biol Chem 1997;272:26827-32.
64. Jump DB, Ren B, Clarke SD, Thelen A. Effects of fatty acids on hepatic gene expression. Prostaglandins Leukot Essent Fatty Acids 1995;52:107-11.
65. Liimatta M, Towle HC, Clarke SD, Jump DB. Fatty acid regulation of hepatic pyruvate kinase gene transcription. Mol Endocrinol 1994;8:1147-53.
66. Jump DB, Clarke SD, MacDougald O, Thelen A. Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes. Proc Natl Acad Sci U S A 1993;90:8454-8.